Dominik Höchli
Direktor/Vorstandsmitglied bei MOLECULAR PARTNERS AG
Aktive Positionen von Dominik Höchli
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| MOLECULAR PARTNERS AG | Direktor/Vorstandsmitglied | 21.04.2021 | - |
| Independent Dir/Board Member | 21.04.2021 | - | |
Catapult Therapeutics BV
 Catapult Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Catapult Therapeutics BV operates as a biopharmaceutical company which develops cancer treatments. It is developing CAP-100, a humanized anti-CCR7 antibody. The company was founded in 2015 and is headquartered in Lelystad, the Netherlands. | Vorstandsvorsitzender | 01.01.2021 | - |
Karriereverlauf von Dominik Höchli
Ehemalige bekannte Positionen von Dominik Höchli
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| AbbVie AG | Corporate Officer/Principal | - | - |
Ausbildung von Dominik Höchli
| University of Bern | Doctorate Degree |
Statistik
International
| Schweiz | 4 |
| Niederlande | 2 |
Operativ
| Director/Board Member | 1 |
| Independent Dir/Board Member | 1 |
| Doctorate Degree | 1 |
Sektoral
| Health Technology | 2 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| MOLECULAR PARTNERS AG | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Catapult Therapeutics BV
Catapult Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Catapult Therapeutics BV operates as a biopharmaceutical company which develops cancer treatments. It is developing CAP-100, a humanized anti-CCR7 antibody. The company was founded in 2015 and is headquartered in Lelystad, the Netherlands. | Commercial Services |
| AbbVie AG |
- Börse
- Insiders
- Dominik Höchli
- Erfahrung
